News
Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...
A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback